Clopidogrel vs aspirin monotherapy following dual antiplatelet therapy after percutaneous coronary intervention: a systematic review and meta-analysis. | 2023 | Current Problems in Cardiology |
Efficacy and safety profile of ticagrelor versus clopidogrel in percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS): a systematic review and meta-analysis. | 2023 | Cureus |
Safety and efficacy of ticagrelor versus clopidogrel in east asian patients with acute coronary syndrome undergoing percutaneous coronary intervention treated with dual antiplatelet therapy: a meta-analysis of randomized controlled trials. | 2023 | Cardiology |
Strategy of dual antiplatelet therapy for patients with ST-elevation myocardial infarction and non-ST-elevation acute coronary syndromes: a systematic review and network meta-analysis. | 2023 | International Journal of Cardiology |
P2Y12 inhibitors for non-ST-segment elevation acute coronary syndrome: a systematic review and network meta-analysis. | 2023 | Texas Heart Institute Journal |
Effect of pretreatment with a P2Y12 inhibitor in patients with non-ST-elevation acute coronary syndrome: a systematic review and network meta-analysis. | 2023 | Frontiers in Cardiovascular Medicine |
P2Y12 inhibitor or aspirin monotherapy for secondary prevention of coronary events. | 2023 | Journal of the American College of Cardiology |
Short-term DAPT and DAPT de-escalation strategies for patients with acute coronary syndromes: a systematic review and network meta-analysis. | 2023 | Circulation. Cardiovascular Interventions |
Efficacy of ticagrelor compared to clopidogrel in improving endothelial function in patients with coronary artery disease: a systematic review. | 2022 | Journal of Cardiovascular Medicine |
Comparison of ticagrelor with clopidogrel in east Asian patients with acute coronary syndrome: a systematic review and meta-analysis of randomized clinical trials. | 2022 | Journal of Cardiovascular Pharmacology |
P2Y12 inhibitor pretreatment in patients with nonST-segment elevation acute coronary syndrome: a meta-analysis. | 2022 | Medicine |
Early vs. delayed initiation of treatment with P2Y12 inhibitors in patients with non-ST-segment elevation acute coronary syndrome: a systematic review and network meta-analysis of randomized controlled trials. | 2022 | Frontiers in Cardiovascular Medicine |
Potent P2Y12 inhibitors versus clopidogrel in elderly patients with acute coronary syndrome: systematic review and meta-analysis. | 2021 | American Heart Journal |
Risk factors for bleeding and clinical ineffectiveness associated with clopidogrel therapy: a comprehensive meta-analysis. | 2020 | Clinical and Translational Science |
Antithrombotic therapy with or without clopidogrel after transcatheter aortic valve replacement. A meta-analysis of randomized controlled trials. | 2020 | Clinical Research in Cardiology |
Long-term effect of clopidogrel in patients with and without diabetes: a systematic review and meta-analysis of randomized controlled trials. | 2020 | World Journal of Diabetes |
Effects of the ABCB1 C3435T single nucleotide polymorphism on major adverse cardiovascular events in acute coronary syndrome or coronary artery disease patients undergoing percutaneous coronary intervention and treated with clopidogrel: a systematic review and meta-analysis. | 2020 | Expert Opinion on Drug Safety |
Comparative efficacy and safety of oral P2Y12 inhibitors in acute coronary syndrome: network meta-analysis of 52 816 patients from 12 randomized trials. | 2020 | Circulation |
Efficacy and safety of newer P2Y12 inhibitors for acute coronary syndrome: a network meta-analysis. | 2020 | Scientific Reports |
Meta-analysis comparing P2Y12 inhibitors in acute coronary syndrome. | 2020 | The American Journal of Cardiology |
Antithrombotic therapy in the early phase of non-ST-elevation acute coronary syndromes: a systematic review and meta-analysis. | 2020 | European Heart Journal. Cardiovascular Pharmacotherapy |
Efficacy and safety of clopidogrel versus prasugrel and ticagrelor for coronary artery disease treatment in patients with CYP2C19 LoF alleles: a systemic review and meta-analysis. | 2020 | British Journal of Clinical Pharmacology |
Comparison of prasugrel and clopidogrel used as antiplatelet medication for endovascular treatment of unruptured intracranial aneurysms: a meta-analysis. | 2019 | American Journal of Neuroradiology |
The effect of CYP2C19 and nongenetic factors on clopidogrel responsiveness in the mena region: a systematic review. | 2019 | Clinical and Applied Thrombosis/Hemostasis |
Optimal duration of aspirin plus clopidogrel after ischemic stroke or transient ischemic attack. | 2019 | Stroke: American Heart Association |
Ticagrelor after pharmacological thrombolysis in patients with ST-segment elevation myocardial infarctions: insight from a trial sequential analysis. | 2019 | Journal of Thrombosis and Thrombolysis |